CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation:: Correlation with time from transplant to receipt of tacrolimus

被引:26
作者
Hassan-Walker, AF
Cuero, ALV
Mattes, FM
Klenerman, P
Lechner, F
Burroughs, AK
Griffiths, PD
Phillips, RE
Emery, VC
机构
[1] UCL Royal Free & Univ Coll Med Sch, Dept Virol, London NW3 2PF, England
[2] UCL Royal Free Hampstead Natl Hlth Serv Trust, Div Hepatobiliary Med, London, England
[3] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England
基金
英国惠康基金;
关键词
D O I
10.1086/319260
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effects of the immunocompromised state after liver transplantation on the frequency of cytomegalovirus-specific cytotoxic T lymphocytes (CTL) were investigated in 93 patients by using HLA class I tetrameric complexes corresponding to HLA-A*0201, HLA-B*0702, HLA-B*0801, and HLA-B*3501 refolded with peptides from the ppUL83 matrix protein. ppUL83 CTL frequencies were suppressed during the first 6 months after transplantation. Patients with >1 HLA-restricted response detected had high correlation among ppUL83 CD8(+) CTL frequencies restricted by different HLA haplotypes (Spearman's rho = .67; P < .0001). There was an inverse correlation among levels of the calcineurin inhibitor, tacrolimus, and ppUL83 CD8(+) CTL frequencies (r = -.31; P = .005), which is consistent with the presence of a large proportion (70%) of activated (CD38(+)) ppUL83 CD8+ CTL within the population of HLA class I tetramer-positive cells.
引用
收藏
页码:835 / 843
页数:9
相关论文
共 49 条
[1]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[2]   Activation antigen expression on human T cells .1. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue [J].
Amlot, PL ;
Tahami, F ;
Chinn, D ;
Rawlings, E .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (01) :176-182
[3]   Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells [J].
Boppana, SB ;
Britt, WJ .
VIROLOGY, 1996, 222 (01) :293-296
[4]   Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease [J].
Bowen, EF ;
Sabin, CA ;
Wilson, P ;
Griffiths, PD ;
Davey, CC ;
Johnson, MA ;
Emery, VC .
AIDS, 1997, 11 (07) :889-893
[5]   Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo [J].
Callan, MFC ;
Tan, L ;
Annels, N ;
Ogg, GS ;
Wilson, JDK ;
O'Callaghan, CA ;
Steven, N ;
McMichael, AJ ;
Rickinson, AB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (09) :1395-1402
[6]   Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation [J].
Cope, AV ;
Sabin, C ;
Burroughs, A ;
Rolles, K ;
Griffiths, PD ;
Emery, VC .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (06) :1484-1490
[7]  
Cope AV, 1997, J MED VIROL, V52, P200, DOI 10.1002/(SICI)1096-9071(199706)52:2<200::AID-JMV14>3.0.CO
[8]  
2-O
[9]   Immunosuppressive strategies in transplantation [J].
Denton, MD ;
Magee, CC ;
Sayegh, MH .
LANCET, 1999, 353 (9158) :1083-1091
[10]   FK506, an immunosuppressant targeting calcineurin function [J].
Dumont, FJ .
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (07) :731-748